Discover 1,087 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,087
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: New Bedford MA, East Greenwich RI, Bridgeport CT,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Blood Sugar Management Studies for Adults With Type 1 Diabetes
for
Diabetes Mellitus, Type 1
Location: Dallas TX, San Bernardino CA, Medford OR
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Weight Loss Studies for Adults With a BMI of 27+, Including People Managing Type 2 Diabetes or Sleep Apnea
for
Obesity, Overweight, Diabetes Mellitus, Type 2,
Location: East Greenwich RI, Waterbury CT, Morehead City NC,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
COPD, Emphysema, and Chronic Bronchitis Studies for Current or Former Smokers
for
Pulmonary Disease, Chronic Obstructive
Location: Philadelphia PA, Morehead City NC, Binghamton NY,
Sex: All
Age: 40 - 70+
Recruiting
FeaturedActive & Responsive
Asthma Control Studies for Adults With Ongoing Symptoms Despite a Daily Inhaler
for
Asthma
Location: Philadelphia PA, Rincon GA, Tomball TX, Albuquerque NM,
Sex: All
Age: 18 - 70+
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
for
Lactating Women on Select DOI,
Location: Durham NC, Pittsburgh PA, Chicago IL, Minneapolis MN,
Sponsor: Duke University
Sex: All
Age: 0+
Code: NCT03511118
Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, Quebec, Stony Brook NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Springfield MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Waterford CT, New Haven CT, Stony Brook NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
for
Myasthenia Gravis, Generalized Myasthenia Gravis
Location: Philadelphia PA, Miami FL, Indianapolis IN, Columbia MO,
Sponsor: Kyverna Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06193889
Phase 2, Phase 3, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
Testing Just-in-Time Adaptive Interventions (JITAIs) to Prevent Goal Disengagement in Response to Weight Regain
for
Overweight or Obesity
Location: Springfield OR
Sponsor: ORI Community and Evaluation Services
Sex: All
Age: 18 - 70+
Code: NCT07708064
Recruiting
Active & Responsive
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer